The mast cell-nerve axis in wound healing: A hypothesis

Wound Repair and Regeneration

Volumn 6, Issue 1, 1998, Pages 8-20

  Gottwald, Thomas ^a   Coerper, Stephan ^a   Schäffer, Michael ^a   Köveker, Gerhard ^a   Stead, Ronald H ^a,b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

^c Holburn Biomedical Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL; HUMAN; MAST CELL; NERVE ENDING; PHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; WOUND HEALING;

ANIMALS; HUMANS; MAST CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE ENDINGS; SENSITIVITY AND SPECIFICITY; WOUND HEALING;

EID: 0031598307     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.1998.60104.x     Document Type: Review

References (160)

1. Mucha KH, Huffman JE. Inflammatory cell stimulation and wound healing in Sphaeridiotrema globulus experimentally infected mallard ducks. J Wild Dis 1991; 27: 428-34.
2. Perdue MH, Marshall J, Masson S. Ion transport abnormalities in inflamed rat jejunum. Involvement of mast cells and nerves. Gastroenterology 1990;98:561-7.
3. Stead RH. Nerve remodeling during intestinal inflammation. Ann NY Acad Sci 1992; 664:443-55.
4. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
5. Stead RH, Bienenstock J. Cellular interactions between the immune and peripheral nervous systems. In: Burger MM, Sordat B, Zinkernagel RM, editors. Cell to cell interaction. Basel: Karger, 1990:170-87.
6. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328: 257-65.
7. Gottwald TP, Hewlett BR, Lhoták Š, Stead RH. Electrical stimulation of the vagus nerve modulates the histamine content of mast cells in the rat jejunal mucosa. Neuroreport 1995;7:313-7.
8. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in dura mater mast cells. Neuroscience 1991;44:97-112.
9. Ferrante F, Ricci A, Felici L, Cavalotti C, Amenta F. Suggestive evidence for a functional association between mast cells and sympathetic nerves in meningeal membranes. Acta Histochem Cytochem 1990;23:637-46.
10. Kiernan JA. A pharmalogical and histological investigation of mast cells in cutaneous axon reflex vasodilation. Q J Exp Physiol 1975;60:123-30.
11. Reich JD, Cazzaniga AL, Mertz PM. The effect of electrical stimulation on the number of mast cells in healing wounds. J Am Acad Dermatol 1991;25:40-6.
12. Dvorak AM, Kissell S. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J Leuk Biol 1991;49:197-210.
13. Franzén L, Ghassemifar R, Malcherek P. Experimental mast cell activation improves connective tissue repair in the perforated rat mesentery. Agents Actions 1991;33:371-7.
14. Taub D, Dastych J, Inamura N. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 1995;154:2393-402.
15. Oehmichen M, Cropelin A, Schmidt V. Quantitative studies of mast cell proliferation at the wound edge: rate of DNA synthesis in intravital and postmortem biopsy. Beitr Gerichtl Med 1990;48:271-6.
16. Mekori YA, Metcalfe DD. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J Immunol 1994;153:2194-203.
17. Levi-Schaffer F, Kupietzky A. Mast cells enhance migration of fibroblasts into an in vitro wound. Exp Cell Res 1990;188:42-9.
18. Mukai H, Nishioka K, Kamimura K. Poikiloderma-like lesions on the neck in atopic dermatitis: a histopathological study. J Dermatol 1990;17:85-91.
19. Enerbäck L. Mast cells in rat gastrointestinal mucosa. 2. Dye binding and metachromatic properties. Acta Pathol Microbiol Scand 1966;66:303-10.
20. Galli DJ. New insights into "the riddle of the mast cell." Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990:62:5-12.
21. Bienenstock J, Befus AD, Denburg JA. Mast cell heterogeneity: basic questions and clinical implications. In: Befus AD, Bienenstock J, Denburg J, editors. Mast cell differentiation and heterogeneity. New York: Raven Press, 1986:391-402.
22. Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med 1991;91:612-24.
23. Nilsson G, Svensson V, Nilsson K. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol 1995;42:76-81.
24. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of human epithelial and endothelial cells. J Biol Chem 1995:270:4689-96.
25. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 1994:180:2027-37.
26. Meade R, Askenase PW, Geba GP. Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity. J Immunol 1992;149:521-8.
27. Hu ZQ, Yamazaki T, Cai Z. Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta. Immunology 1994:82:482-6.
28. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990;86:599-605.
29. Bedarida G, Bushell E, Blaschke TF, Hoffman BB. H1- and H2-histamine receptor-mediated vasodilation varies with aging in humans. Clin Pharmacol Ther 1995;58:73-80.
30. Beyak M, Vanner S. Histamine H1 and H3 vasodilator mechanisms in the guinea pig ileum. Gastroenterology 1995;108:712-8.
31. Gyorfi A, Fazekas A, Posch E, Irmes F, Rosivall L. Role of histamine in the development of neurogenic inflammation of rat oral mucosa. Agents Actions 1991;32:229-36.
32. Lieberman P. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions. J Allergy Clim Immunol 1990;86:684-6.
33. Alving K, Matran R, Lacroix JS, Lundberg LM. Capsaicin and histamine antagonist-sensitive mechanisms in the immediate allergic reaction of pig airways. Acta Physiol Scand 1990;138:49-60.
34. Kowalski ML, Kaliner MA. Neurogenic inflammation, vascular permeability, and mast cells. J Immunol 1988;140:3905-10.
35. Kiernan JA. Degranulation of mast cells in the trachea and bronchi of the rat following stimulation of the vagus nerve. Int Arch Allergy Appl Immunol 1990;91:398-402.
36. Williams RM, Bienenstock J, Stead RH. Mast cells: the neuroimmune connection. Chem Immunol 1995;61:208-35.
37. Clark RAF. Wound repair. Overview and general considerations. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press, 1994.
38. Chakravarty N. Regeneration of mast cells after histamine secretion: changes in histidine decarboxylase activity and heparin synthesis. Acta Pharmacol Toxicol Copenh 1983;52: 281-6.
39. Meininger CJ, Zetter BR. Mast cells and angiogenesis. Semin Cancer Biol 1992;3:73-9.
40. Poole TJ, Zetter BR. Stimulation of rat peritoneal mast cel-migration by tumor-derived peptides. Cancer Res 1983; 43:5857-61.
41. Columbo M, Bochner BS, Marone G. Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. J Immunol 1995;154:6058-64.
42. Thompson HL, Burbelo PD, Yamada Y, Kleinman HK, Metcalfe DD. Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J Immunol 1989;143:4188-92.
43. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992;79:958-63.
44. Columbo M, Horowitz EM, Botana LM. The human recombinant c-kit ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992;149:599-608.
45. Metcalfe DD, Mekori JA, Rottem M. Mast cell ontogeny and apoptosis. Exp Dermatol 1995;4:227-30.
46. Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 1994;152:5860-7.
47. Iemura A, Tsai M, Ando A. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1993;142:965-74.
48. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72:215-22.
49. Qu Z, Liebler JM, Powers MR. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995;147:564-73.
50. D'Amore PA. Heparin-endothelial cell interactions. Haemostasis 1990; 20 (Suppl 1) 159-65.
51. Gao G, Goldfarb M. Heparin can activate a receptor tyrosine kinase. EMBO J 1995;14:2183-90.
52. Gajdusek CM, Luo Z, Mayberg MR: Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol 1993;157:133-44.
53. Joseph-Silverstein J, Rifkin DB. Endothelial cell growth factors and the vessel wall. Semin Thromb Hemost 1987;13:504-13.
54. D'Amore PA. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 1990;9:227-38.
55. Flint N, Cove FL, Evans GS. Heparin stimulates the proliferation of intestinal epithelial cells in primary culture. J Cell Sci 1994;107:401-11.
56. Norrby K. Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc Res 1994;48:96-113.
57. Baird A, Esch F, Mormede P. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res 1986;42:143-205.
58. Gospodarowicz D, Ferrara N, Schweigerer L. Characterization and biological functions of fibroblast growth factor. Endocr Rev 1987;8:95-114.
59. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
60. Burgess WH, Maciag T. The heparin binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
61. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109: 1-6.
62. Halaban R, Langdon R, Birchall N. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988;107:1611-9.
63. Hughes SE, Hall PA. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993;69:173-82.
64. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 1990;137:85-92.
65. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-40.
66. Fleming MG, Howe SF, Candel AG. Immunohistochemical localization of cytokines in nevi. Am J Dermatopathol 1992;14:496-503.
67. Baird A, Schubert D, Ling N, Guillemin R. Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci USA 1988;85:2324-8.
68. Mignatti P, Rifkin DB. Release of basic fibroblast growth factor, an angiogenic factor devoid of a secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 1991;47:201-7.
69. Schweigerer L, Neufeld G, Friedman J. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987;325:257-9.
70. Villaschi S, Nicosia R. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993;143:181-90.
71. Roche WR. Mast cells and tumour angiogenesis: the tumour-mediated release of an endothelial growth factor from mast cells. Int J Cancer 1985;36:721-8.
72. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992;90:1479-85.
73. Dastych J, Costa JJ, Thompson HL, Metcalfe DD. Mast cell adhesions to fibronectin. Immunology 1991;73:478-84.
74. Gorospe JR, Tharp MD, Hinckley J, Kornegay JN, Hoffman EP. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci 1994;122:44-56.
75. Purves D, Snider WD, Voyvodic TJ. Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature 1988;336:123-6.
76. Madison RD, Archibald SJ, Krarup C. Peripheral nerve injury. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: Saunders, 1992:450-89.
77. Terenghi G. Peripheral nerve injury and regeneration. Histol Histopathol 1995;10:709-18.
78. Stead RH. Innervation of the mucosal immune cells in the gastrointestinal tract. Reg Immunol 1992;4:91-9.
79. Cooke HJ. Neurobiology of the intestinal mucosa. Gastroenterology 1986;90:1057-81.
80. Stanisz AM, Stead RH, Williams RM. Innervation of inflammatory cells. In: Agrawal D, Townley R, editors. Immunopharmacology of allergic diseases. New York: Marcel Dekker, 1995;159-81.
81. Gabella G. Innervation of the gastrointestinal tract. Int Rev Cytol 1979;59:129-93.
82. Burnstock G. Autoimmune neural control mechanisms with special reference to the airways. In: Kaliner MA, Barrnes PJ, editors. The airways. Neural control in health and disease. New York: Marcel Dekker, 1988:1-22.
83. Waris T. Reinnervation of free skin autografts in the rat. Plast Reconstr Surg 1978;12:85-93.
84. Waris T. Degeneration and regeneration in a dorsal skin flap in the rat. Scand J Plast Reconstr Surg Hand Surg 1978;12:95-103.
85. Kishimoto S, Maruo M, Ohse C. The regeneration of the sympathetic catecholaminergic nerve fibers in the process of burn wound healing in guinea pigs. J Invest Dermatol 1982;79:141-6.
86. Kishimoto S. The regeneration of substance P-containing nerve fibers in the process of burn wound healing in the guinea pig skin. J Invest Dermatol 1984;83:219-23.
87. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175-83.
88. Bruce AN. Vasodilator axon reflexes. Q J Exp Physiol 1913;6:339-54.
89. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991;143:S55-S58.
90. Kowalski ML, Didier A, Kaliner MA. Neurogenic inflammation in the airways: neurogenic stimulation induces plasma protein extravasation into the rat airway lumen. Am Rev Respir Dis 1989;140:101-9.
91. Levine JD, Dardick SJ, Basbaum AI, Scipio E. Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. Neuroscience 1985;5:1380-6.
92. Foreman JC, Jordan IC, Piotrowski W. Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol 1982;27:459-61.
93. Ottaway CA. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin. North Am 1991;20:511-29.
94. Piotrowski W, Foreman JC. On the action of substance P, somatostatin and vasoactive intestinal polypeptide on rat peritoneal mast cells and human skin. Arch Pharmacol 1985;331:364-8.
95. Foreman JC. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol 1987;82:366-71.
96. Shanahan F, Lee TD, Bienenstock J, Befus AD. The influence of endorphins on peritoneal and mucosal mast cell secretion. J Allergy Clin Immunol 1984;74:449-504.
97. Shanahan F, Denburg JA, Fox J, Beinenstock J, Befus D. Mast cell heterogeneity effects of neuroenteric peptides on histamine release. J Immunol 1985;135:1331-7.
98. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-85.
99. Stead RH, Tomioka M, Riddell RM, Bienenstock J. SP and/or CGRP are present in subepithelial enteric nerves apposed to intestinal mucosal mast cells. In: McDermott RP, editor. Inflammatory bowel disease. New York: Excerpta Medica, 1988:43-8.
100. Williams RM, Singh J, Sharkey KA. Innervation of mast cells of the exorbital lacrimal gland: the effects of age. J Auton Nerv Syst 1994;47:95-108.
101. Gu XH, Terenghi G, Kangesu T, Navsaria HA, Springall DR, Leigh IM, Green CJ, Polak JM. Regeneration pattern of blood vessels and nerves in cultured keratinocyte grafts assessed by confocal laser scanning microscopy. Br J Dermatol 1995;132:376-83.
102. Marfurt CF, Ellis LC, Jones MA. Sensory and sympathetic nerve sprouting in the rat cornea following neonatal administration of capsaicin. Somatosens Mot Res 1993;10:377-98.
103. Liu HM, Lei HY, Kao KP. Correlation between NGF levels in wound chamber fluid and cytological localization of NGF and NGF receptor in axotomized rat sciatic nerve. Exp Neurol 1995;132:24-32.
104. Lindholm D. Interleukin 1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987;330:658-9.
105. Register B, Delree P, Leprince P, Martin D, Sadzot C, Malgrange B, Manaut C, Rigo JM, Lefebre PP, Octave JN. Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 1993;34:32-43.
106. Pearce F, Thompson H. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986;372:379-93.
107. Matsuda H, Coughlin M, Bienenstock J, Denburg J. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988;85:6508-12.
108. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989;86:10,059-63.
109. Lewis T, Marvin H. Observations relating to vasodilation arising from antidromic impulses, to herpes zoster and trophic effects. Heart 1927;14:27-46.
110. Bayliss W. On the origin from the spinal cord of vasodilator fibers of the hind limb, and on the nature of these fibers. J Physiol 1901;26:173-209.
111. Lewis T. The nocifensor system of nerves and its reactions. Br Med J 1927;1:431-5.
112. Lusthaus S, Shoshan S, Benmeir P, Weinberg A, Wexler MR. Effect of denervation on incision wound scars in rabbits. J Geriatr Dermatol 1993;1:11-4.
113. Nagy J, Iversen L, Goedert M, Chapman D, Hunt SP. Dose dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 1983;3:399-406.
114. Kjartansson J, Dalsgaard CJ, Jonsson CE. Decreased survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plast Reconstr Surg 1987;79:218-21.
115. Thompson HL, Burbelo PD, Metcalfe DD. Regulation of adhesion of mouse bone marrow-derived mast cells to laminin. J Immunol 1990;145:3425-31.
116. Bassett CA. Beneficial effects of electromagnetic fields. J Cell Biochem 1993;51:387-93.
117. Ekblad E, Winther C, Ekman R, Hakanson R, Sundler F. Projections of peptide-containing neurons in rat small intestine. Neuroscience 1987;20:169-88.
118. Heine H, Forster FJ. Relationships between mast cells and preterminal nerve fibers. Z Mikrosk Anat Forsch 1975;89:34-7.
119. Eady RA, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 1979;100:623-33.
120. Alving K, Sundstrom C, Matran R, Panula P, Hokfelt T, Lundberg JM. Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs. Cell Tiss Res 1991;264:529-38.
121. Cocchiara R, Albeggiani G, Azzolina A, Bongiovanni A, Lampiasi N, Di Blasi F, Geraci D. Effect of substance P on uterine mast cell cytokine release during the reproductive cycle. J Neuroimmunol 1995;60:107-15.
122. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-85.
123. Bani-Sacchi T, Barattini M, Bianchi S. The release of histamine by parasympathetic stimulation in guinea pig auricle and rat ileum. J Physiol 1986;371:29-38.
124. Leff AR, Stimler NP, Munoz NM, Shioya T, Tallet J, Dame C. Augmentation of respiratory mast cell secretion of histamine caused by vagus nerve stimulation during antigen challenge. J Immunol 1986;136:1066-73.
125. Kreis ME, Kirkup HD, Becker HD, Grundy D. Sensitivity of mesenteric afferents supplying the rat jejunum to the mast cell mediator histamine. Gastroenterology 1997;112:A636.
126. Theodorou V, Fioramonti J, Bueno L. Integrative neuroimmunology of the digestive tract. Vet Res 1996;27:427-42.
127. Leon A, Buriani A, Dal-Toso R, Fabus M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
128. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity 1994;19:141-50.
129. Paus R, Luftl M, Czarnetzki BM. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 1994;130:174-80.
130. Yurt RW. Role of mast cell in trauma. In: Dineen P, Hildick-Smith G, editors. The surgical wound. Philadelphia: Lea & Febiger,1981;37-62.
131. Tharp MD. The mast cell and its role in human cutaneous diseases. Progr Dermatol 1987;21:1-14.
132. Tharp MD, Suvunrungsi RT, Sullivan TJ. IgE-mediated release of histamine from human cutaneous mast cells. J Immunol 1983;130:1896-901.
133. Kaka JS, Hutschenreiter G, Waidelich W. Effect of low-power density laser radiation on healing of open skin wounds in rats. Arch Surg 1981;116:293-6.
134. Mester E, Toth N, Mester A. The biostimulative effect of laser beam. Laser Basic Biomed Res 1982;22:4-7.
135. Gougon C, Divol J, Moulin G. Preliminary results of mid-laser treatment of chronic ulcerations of the legs [abstract]. Proceedings of the sixth Congress of the International Society of Laser Surgery and Medicine, 1985:78.
136. Dyson M, Young S. Effect of laser therapy on wound contraction and cellularity in mice. Lasers Med Sci 1986;1:125-30.
137. McCulloch J. Physical modalities in wound management: ultrasound, vasopneumatic devices and hydrotherapy. Ostomy Wound Manage 1995;41:30-2, 34, 36-37.
138. Gentzkow GD. Electrical stimulation to heal dermal wounds. J Dermatol Surg Oncol 1993;19:753-8.
139. Gentzkow GD, Miller KH. Electrical stimulation for dermal wound healing. Clin Podiatr Med Surg 1991;8:827-41.
140. Wolcott LE, Wheeler PC, Hardwicke HM, Rowley BA. Accelerated healing of skin ulcers by electrotherapy: preliminary clinical results. South Med J 1969;62:796-9.
141. Gault WR, Gatens P, Wolcott L. Acceleration of healing rate in ischemic skin ulcers with low intensity direct current (LIDC) [abstract]. Preparation for A.P.T.A. meeting, Las Vegas, Nevada, 1972:1-7.
142. Gault WR, Gatens P. Use of low intensity direct current in management of ischemic skin ulcers. Phys Ther 1976;56:265-9.
143. Akers TK, Gabrielson AL. The effect of high voltage galvanic stimulation on the rate of healing of decubitus ulcers. Biomed Sci Instrum 1984;20:99-100.
144. Carley PJ, Wainapel SF. Electrotherapy for acceleration of wound healing: low intensity direct current. Arch Phys Med Rehab 1985;66:443-6.
145. Kloth L, Feedar J. Acceleration of wound healing with high voltage, monophasic, pulsed current. Phys Ther 1988;68:503-8.
146. Barron JJ, Jacobson WE, Tidd G. Treatment of decubitus ulcers, a new approach. Minn Med 1985;68:103-6.
147. Alon G, Azaria M, Stein H. Diabetic ulcer healing using high voltage TENS [abstract]. Phys Ther 1986;66:775-82.
148. Fakhri O, Amin M. The effect of low-voltage electric therapy on the healing of resistant skin burns. J Burn Care Rehab 1987;8:15-8.
149. Jercinovic A, Bohanovic F. Pressure sore healing and endogenous potential [abstract]. Bioelectrical Repair and Growth Society Transactions, Tenth Annual Meeting, Bioelectrical Repair and Growth Society, Philadelphia, October 1990:14-7.
150. Griffin JW, Tooms RE, Mendius RA, Clifft JR, Vander Swaag R, EI-Zeky F. Efficacy of high voltage pulsed current for healing of pressure ulcers in patients with spinal cord injury. Phys Ther 1991;71:433-44.
151. Reich JD, Tarlan PP. Electrical stimulation of skin. Int J Dermatol 1990;29:395-400.
152. Newton R. High voltage pulsed galvanic stimulation: theoretical bases and clinical applications. In: Currier, N, editor. Clinical electrotherapy. Norwalk: Appleton-Century-Crofts, 1987:165-82.
153. Weiss DS, Eaglstein WH, Falanga V. Exogenous electric current can reduce the formation of hypertrophic scars. J Dermatol Surg Oncol 1989;15:1272-5.
154. El Sayed SO, Dyson M. Comparison of the effect of multiwavelength light produced by a cluster of semiconductor diodes and of each individual diode on mast cell number and degranulation in intact and injured skin. Lasers Surg Med 1990; 10: 559-68.
155. Vallejo AN, Jr, Ellis AE. Ultrastructural study of the response of eosinophil granule cells to Aeromonas salmonicida extracellular products and histamine liberators in rainbow trout Salmo gardneri Richardson. Dev Comp Immunol 1989;13:133-48.
156. Shin J, Kang HS, Chung IH, Lew JD, Lee YD, Cho BP, Shin TS. An electron microscopic study on mast cell degranulation and regeneration in rats. Yonsei Med J 1986;27:30-40.
157. Ammer K. Elektrotherapie. Wien Med Wochenschr 1994; 144:60-5.
158. Hebda PA, Collins MA, Tharp M. Mast cell and myofibroblast in wound healing. Dermatol Clin. 1993;11:685-96.
159. Gobara M, Akino H, Tsuka H, Takahashi M, Okada K. Morphological changes in major pelvic ganglion neurons and histological structure of bladder using rat model of partial urethal ligation. Hinyokika Kiyo Acta Urol Jap 1995;41:259-67.
160. Edlich RF, Rodeheaver GT, Thacker JG. Surgical devices in wound healing management. In: Cohen ID, Diegelmann RF, Lindblad WJ, editors. Wound healing, biochemical and clinical aspects. Philadelphia: Saunders, 1992:581-600.